Products

Trader's Journal

Know why you win. Know why you lose.

thetradersjournal.app Finance / Investing & Trading

Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$6.67/mo
Lower than 86% of peersNiche median $19/mo
Creators
Trader'sJournal
No social account linked
Launched
47d ago
2026-10-06 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Know why you win. Know why you lose. Imports you can't edit.

    Oct 6 · 47d agoLaunch page

    At the time: <5K visits/mo

Traffic sources

Oct 2026

Traffic breakdown

No traffic channel or country breakdown data for this website yet.

Search

Domain authority —Domain registered Unknown

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

1-year license
$79.99/yr
one year of use

Trial: None · 1 paid tier ($79.99) · Observed 2026-11-08 · Source page

Entry price $6.67/mo, Lower than 86% of peers; “Investing & Trading” median is $19/mo.View pricing benchmark

Website snapshots

Indexed 2026-10-06

Key pages

Desktop & mobile archive
thetradersjournal.app/ Snapshot 2026-11-08

Questions & evidence

How much does Trader's Journal cost?
1-year license: $79.99/yr. Observed 2026-11-08. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Trader's Journal get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Trader's Journal and what platforms does it support?
Trader's Journal is catalogued under Investing & Trading: Know why you win. Know why you lose. Supported platforms: Web.

Related products in this category

Finance / Investing & Trading

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.